Project Director, Strategy and Commercialization
Parsippany, New Jersey
How many opportunities exist for you to work on something truly ground breaking?
Imagine developing the next-stage business strategy for a fast growth biotechnology company that will have a truly global impact on cardiovascular disease.
Your ability to envision, make choices, align stakeholders and implement change will impact the future for your company and positively impact health outcomes for millions.
Talent Orchard LLC, a boutique talent acquisition consulting firm has been retained under contract to assist a growth oriented Biotechnology company in completing a critical search for a Director, able to develop and execute an effective and innovative commercialization strategy to be implemented upon regulatory approval for a major new drug.
Coronary artery disease is the #1 cause of death globally and has become the leading burden on healthcare.
How can coronary artery disease be tackled?
First with prevention. But these efforts take generations to implement; at enormous costs; without complete effect.
Second with intervention. When prevention programs are absent or fail, the risk of death is high. It jumps dramatically the moment that an atherosclerotic plaque in a coronary or cerebral artery ruptures. Thrombosis that follows may block the artery, cut of oxygen supply and kill in a matter of minutes. We want to stop and reverse this deadly progression of cardiovascular disease.
As our client's CEO Dr. Clive Meanwell stated the new drug under development has “game-changing potential to address the unmet needs of millions of at risk…patients worldwide who continue to struggle with high cholesterol”.
What if YOU were part of the leadership team that brought that scale of change to the market?
What if YOU were part of the team that developed a therapeutic solution built upon the convergence of Nobel Prize winning science and a proven track-record for innovative drug development and in doing so, changed an industry?
How satisfying would it be to know YOU changed the health outcomes for the better for millions of people around the world and in the process reduced the rising cost of care?
Millions of people take statins every day to help manage their LDL-C cholesterol levels and have done so for years. Recent research has identified PCSK9 as a new target, opening the door for new treatments that could significantly improve patient outcomes, however the initial products are too expensive for the outcomes they deliver.
Our client is bringing to market a new product that will change the paradigm. Phase II trials indicate significant lowering of LDL-C via a treatment that may only need to be taken twice a year and delivered at a price point far more affordable than competitors. Utilizing Nobel Prize winning methods for RNA interference that targets PCSK9 and silences it, the new treatment enables the body to more effectively lower “bad” cholesterol and possibly your risk of dying from heart disease.
As the Project Director, Strategy and commercialization;
Are you ready for that opportunity?
Working with senior leadership, are you ready to;
Established in 2010, Talent Orchard has an exceptional reputation, providing staffing solutions to time-sensitive, talent scarcity issues to deliver better talent management ROI. Our specialty lies in the critical area of program talent acquisition and resource management, not in one narrow skillset, but across many areas of technical and functional delivery.
To learn more about our other exciting opportunities, visit our Jobs Page at www.talentorchard.com.